Harmony Biosciences Holdings, Inc. (HRMY) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.24B, a trailing price-to-earnings ratio of 9.8 and a free-cash-flow yield of 15.5%. Over the most recent reported fiscal year, revenue grew 21.5% and free cash flow per share grew 57.3%.